Bio Essence (BIOE) Receivables - Other (2022 - 2024)

Bio Essence (BIOE) recorded quarterly Receivables - Other of $197294.0 in Q3 2024, little changed quarter-over-quarter from $197294.0 in Q2 2024.

Bio Essence (BIOE) Receivables - Other (2022 - 2024) Analysis & Trends

Bio Essence's Receivables - Other history runs 3 years deep, the most recent figure standing at $197294.0 for Q3 2024.

  • In Q3 2024, Receivables - Other changed N/A year-over-year to $197294.0; the TTM figure through Sep 2024 stood at $197294.0 (changed N/A YoY), while the FY2023 annual figure was $877749.0, up 45.13% from the prior year.
  • Receivables - Other was $197294.0 for Q3 2024 at Bio Essence, roughly flat from $197294.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $877749.0 in Q4 2023 to a low of $197294.0 in Q2 2024.
  • Historically, Receivables - Other has averaged $550974.2 across 3 years, with a median of $604785.0 in 2022.
  • Biggest YoY gain for Receivables - Other was 45.13% in 2023; the steepest drop was 45.13% in 2023.
  • A 3-year view of Receivables - Other shows it stood at $604785.0 in 2022, then soared by 45.13% to $877749.0 in 2023, then tumbled by 77.52% to $197294.0 in 2024.
  • The last three Receivables - Other figures came in at $197294.0 (Q3 2024), $197294.0 (Q2 2024), and $877749.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Bio Essence - - 319,353.00

Historic Data

Download Data
DateValue
Sep 30, 2024 197,294.00
Sep 30, 2024 197,294.00
Jun 30, 2024 197,294.00
Jun 30, 2024 197,294.00
Mar 31, 2024 877,749.00
Mar 31, 2024 877,749.00
Dec 31, 2023 877,749.00
Dec 31, 2023 877,749.00
Dec 31, 2022 604,785.00
Dec 31, 2022 604,785.00